Latest total revenue for FMS: $19B, below the Healthcare sector average of $110B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), FMS shows a total revenue of $19B. That compares with $20B in the prior-year period — down 0.5% year over year. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, FMS's total revenue is now $19B (was $20B) — a 0.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Fresenius Medical Care AG is outperforming or lagging.
The Healthcare sector average total revenue is about $110B. Fresenius Medical Care AG is at $19B, which is lower that average. That is roughly 82.8% below the sector mean. Use the comparison chart on this page to see how FMS stacks up against individual peers as well.
Tracking FMS's total revenue over time shows whether Fresenius Medical Care AG is scaling, shrinking, or reshaping that part of the business. The current reading is $19B That compares with $20B in the prior-year period — down 0.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total revenue page, Stockcircle has Fresenius Medical Care AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $19B) with ownership activity and broader fundamentals.